GenCanna Acquires London-Based CBD Provider, CBD Capital

U.S. CBD manufacturer GenCanna has acquired a key foothold in the European CBD market with its successful acquisition of London-based CBD Capital. The deal significantly increases GenCanna’s expanding bulk ingredient and finished goods operations in the United Kingdom and key European and global markets.

GenCanna, an industry founding producer of premium full-spectrum and broad-spectrum CBD and other quality cannabinoids for bulk supply and finished goods formulation, will be looking to capitalise on its international expansion through CBD Capital’s enviable position as the leading provider of CBD distillate, isolate, and water-soluble bulk ingredients as well as white and private label services to the United Kingdom, the European Union and markets worldwide…

Continue reading on Cannyx News.